ICCM News and Press, IceCure Medical Ltd. From 02/01/22

Gainers: Biofrontera (NASDAQ:BFRI) +14%. Synaptogenix (NASDAQ:SNPX) +11%. IceCure Medical (NASDAQ:ICCM) +10%. Immunic (NASDAQ:IMUX) +10%. Oncternal Therapeutics (NASDAQ:ONCT) +10%. Losers: Sio Gene Therapies (NASDAQ:SIOX) -19%. Anavex Life Sciences (NASDAQ:A...

IceCure Medical Announces Preliminary Unaudited 2021 Year-End Financial Results Revenue increase driven by sales through distribution agreements for IceCure's groundbreaking minimally-invasive cryoablation tumor destruction technology. Robust balance sheet supports global ro...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to dive into another day of investing with the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com Moving stocks this morning are FDA updates, merge...

IceCure Medical CEO Issues Letter to Shareholders PR Newswire CAESAREA, Israel , Jan. 5, 2022 /PRNewswire/ --  IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSens...

Gainers: Microbot Medical (NASDAQ:MBOT) +51%, CollPlant Biotechnologies (NASDAQ:CLGN) +27%, Lucira Health (NASDAQ:LHDX) +14%, IceCure Medical (NASDAQ:ICCM) +13%, Cue Health (NASDAQ:HLTH) +12%. Losers: BridgeBio Pharma (NASDAQ:BBIO) -71%, Biond...

IceCure Medical Receives Notice of Intention to Grant a European Patent Covering Its Cryogenic Pump PR Newswire CAESAREA, Israel , Dec. 20, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minima...

IceCure Medical (ICCM -11.1%) trades 10% higher premarket on announcing the closing of its underwritten public offering of 3.89M shares of the Co.'s ordinary shares, inclusive of 0.58M shares offered pursuant to the underwriters' over-allotment option, at a price to the public ...

Galera Therapeutics (NASDAQ:GRTX) +138% announces primary endpoint met statistical significance in corrected topline efficacy data of phase 3 ROMAN trial of avasopasem. Nuverra Environmental Solutions (NYSE:NES) +33%. Terminix Global Holdings (NYSE:TMX) +25%. MIND Technology (NASDAQ:MIND...

IceCure Medical Ltd. Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option PR Newswire CAESAREA, Israel , Dec. 13, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the " Company " or " IceCur...

Gainers: Inspira Technologies (NASDAQ:IINN) +92%. Ensysce Biosciences (NASDAQ:ENSC) +79%. Insignia (NASDAQ:ISIG) +44%. Hovnanian Enterprises (NASDAQ:HOVNP) +33%. American Virtual Cloud Technologies (NASDAQ:AVCT) +31%. Blue Star Foods Corp. (NASDAQ:BSFC) +16%. Hovnanian (NYSE:HO...